[{"address1": "28 Liberty Street", "address2": "39th Floor", "city": "New York", "state": "NY", "zip": "10005", "country": "United States", "phone": "646 305 6387", "fax": "646 882 4228", "website": "https://beyondspringpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.", "fullTimeEmployees": 73, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lan  Huang Ph.D.", "age": 52, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. G. Kenneth Lloyd", "age": 79, "title": "Chief Scientific Officer", "yearBorn": 1944, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Linqing  Jia", "title": "Co-Founder", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Stephen  Kilmer", "title": "Head of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregg  Russo", "title": "Senior Vice President of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 2.9, "open": 2.9, "dayLow": 2.85, "dayHigh": 3.0, "regularMarketPreviousClose": 2.9, "regularMarketOpen": 2.9, "regularMarketDayLow": 2.85, "regularMarketDayHigh": 3.0, "beta": -0.05, "forwardPE": -6.255319, "volume": 157499, "regularMarketVolume": 157499, "averageVolume": 190093, "averageVolume10days": 839710, "averageDailyVolume10Day": 839710, "bid": 2.96, "ask": 3.05, "bidSize": 3000, "askSize": 1800, "marketCap": 114705576, "fiftyTwoWeekLow": 0.653, "fiftyTwoWeekHigh": 4.0, "priceToSalesTrailing12Months": 74.0036, "fiftyDayAverage": 1.4307, "twoHundredDayAverage": 1.09734, "currency": "USD", "enterpriseValue": 107185496, "floatShares": 23874350, "sharesOutstanding": 39015500, "sharesShort": 1884506, "sharesShortPriorMonth": 1986424, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.048299998, "heldPercentInsiders": 0.26471, "heldPercentInstitutions": 0.14083, "shortRatio": 25.6, "shortPercentOfFloat": 0.0793, "impliedSharesOutstanding": 39015500, "bookValue": -0.464, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -27510000, "trailingEps": -0.71, "forwardEps": -0.47, "enterpriseToRevenue": 69.152, "enterpriseToEbitda": -3.621, "52WeekChange": 1.5344827, "SandP52WeekChange": 0.29495108, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BYSI", "underlyingSymbol": "BYSI", "shortName": "BeyondSpring, Inc.", "longName": "BeyondSpring Inc.", "firstTradeDateEpochUtc": 1489069800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "13bae88f-b6da-35bd-a612-d48b2fa6eb85", "messageBoardId": "finmb_409784135", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.94, "targetHighPrice": 1.25, "targetLowPrice": 1.25, "targetMeanPrice": 1.25, "targetMedianPrice": 1.25, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 15394000, "totalCashPerShare": 0.395, "ebitda": -29597500, "totalDebt": 4471000, "quickRatio": 2.257, "currentRatio": 3.781, "totalRevenue": 1550000, "revenuePerShare": 0.04, "returnOnAssets": -0.38693002, "revenueGrowth": 0.294, "grossMargins": 1.0, "operatingMargins": -15.410291, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-17"}]